Table 4.
linear regression model for PCS and MCS for typology of multimorbidity
| PCS | MCS | |
|---|---|---|
| Coefficient [95% CI] | Coefficient [95% CI] | |
| Arthritis | − 0.93 [− 1.81 to − 0.05]* | − 0.69 [− 2.02 to − 0.03]* |
| Diabetes | 0.39 [− 1.10 to 1.90] | 1.12 [− 0.69 to 2.93] |
| Hypertension | 0.09 [− 0.68 to 0.86] | −2.09 [− 3.23 to − 0.95]* |
| CLD | −1.56 [− 3.03 to − 0.10* | −0.48 [− 3.40 to 2.45] |
| APD | 0.15 [− 0.50 to 0.80] | −2.11 [− 3.11 to − 1.10]* |
| CBA | −0.50 [− 1.51 to − 0.05]* | −0.21 [− 1.71 to 1.29] |
| Vision problem | − 0.01 [− 1.46 to 1.43] | −2.92 [−4.55 to − 1.30]* |
| Deafness | 0.89 [− 2.87 to 4.66] | − 1.94 [−6.43 to 2.54] |
| Epilepsy | − 2.85 [− 4.56 to − 1.14]* | −3.26 [− 6.50 to − 0.03]* |
| Alcohol problem | 0.75 [− 2.68 to 4.18] | −2.82 [− 5.37 to − 0.28]* |
| Thyroid | 0.89 [−1.76 to 3.54] | − 0.06 [− 5.03 to 4.89] |
| Tuberculosis | − 1.69 [− 3.91 to 0.52] | −3.84 [− 6.25 to − 1.44]* |
| Filariasis | 1.31 [− 1.40 to 4.04] | − 3.44 [− 5.03 to − 1.84]* |
| Depression | 3.59 [0.68 to 6.50]* | −6.77 [− 12.51 to − 1.02]* |
| Hypotension | −1.79 [− 4.01 to 0.41] | −0.58 [− 4.51 to 3.34] |
| APD + HTN | −1.39 [− 2.65 to − 0.13]* | 1.55 [− 0.29 to 3.40] |
| APD + ART | − 0.0 [− 1.26 to 1.06] | 0.50 [−1.26 to 2.26] |
| APD + CBA | 0.26 [−0.83 to 1.35] | − 0.03 [− 1.85 to 1.78] |
| APD + VI | 0.09 [− 1.66 to 1.86] | −0.04[− 2.13 to 2.04] |
| APD + DI | −0.31 [− 2.21 to 1.59] | 1.07 [− 2.14 to 4.30] |
| APD + CLD | 0.52[− 2.73 to 3.76] | 2.22 [−1.43 to 5.89] |
| APD + DF | − 1.81 [− 4.72 to 1.08] | 3.19 [− 2.60 to 9.00] |
| HTN + ART | − 0.87 [− 2.74 to 1.01] | 1.11 [−1.43 to 3.67] |
| HTN + DI | 0.63 [− 125 to 2.52] | −1.28 [− 2.74 to − 0.30]* |
| HTN + CBA | −1.11[− 2.72 to 0.49] | −0.06 [− 2.52 to 2.38] |
| HTN + VI | −0.47 [− 2.98 to 2.04] | −1.84 [− 4.14 to 0.45] |
| ART + CBA | − 0.65 [− 1.09 to − 0.09]* | −0.79 [− 1.27 to − 0.06]* |
| ART + VI | −0.31 [− 1.13 to − 0.06]* | −0.33 [− 1.72 to − 0.05]* |
| ART + DI | 0.07 [− 2.91 to 3.05] | 0.80 [− 3.73 to 5.34] |
| APD + HTN + CBA | −1.45 [−3.23 to − 0.33]* | −0.18 [− 2.90 to 2.35] |
| APD + HTN + DI | −1.28 [− 3.85 to 1.27] | −1.80 [− 4.68 to − 0.09]* |
| HTN + ART+CBA | −0.89 [− 3.19 to − 0.32]* | 1.23 [− 2.16 to 4.63] |
| HTN + ART+DI | 2.75 [− 0.10 to 5.61] | −3.14 [− 6.32 to − 0.03]* |
| APD_ART_VI | −0.56 [− 2.89 to 1.75] | −0.60 [− 3.36 to 2.15] |
| ART+CBA + CLD | −3.13 [− 9.24 to − 0.09]* | 2.66 [− 3.37 to 8.71] |
| ART+CBA + VI | −0.54 [− 3.26 to 2.17] | 0.23 [− 3.74 to 4.20] |
| APD + CBA + VI | −1.46 [− 3.81 to 0.88] | 0.95 [− 2.87 to 4.77] |
*Significant false discovery rate adjusted p value < 0.05; adjusted for age, sex, caste, education, income, marital status, religion, multimorbidity, place of living and Facility
APD Acid peptic disease, HTN Hypertension, ART Arthritis, DI Diabetes, CBA Chronic backache, VI Visual impairment, DF Deafness, CLD Chronic lungs disease